Artal Group S.A.'s Form 4 filing
Omega Therapeutics, Inc. (OMGA) · filed Aug 3, 2021
- Accession no.
- 0000899243-21-031304
- Filed
- Aug 3, 2021, 5:16 PM ET
- Trade date
- Jul 30-Aug 3, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $16.1M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Artal Group S.A.CIK 0001053906 | 10% Owner |
| Artal International S.C.A.CIK 0001218180 | 10% Owner |
| Westend S.A.CIK 0001283968 | 10% Owner |
| Invus Public Equities Advisors, LLCCIK 0001340096 | 10% Owner |
| Invus Public Equities, L.P.CIK 0001340097 | 10% Owner |
| Stichting Administratiekantoor WestendCIK 0001460840 | 10% Owner |
| Artal International Management S.A.CIK 0001522131 | 10% Owner |
| Artal Treasury LtdCIK 0001766952 | 10% Owner |
| Wittouck AmauryCIK 0001841311 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2021 | Common Stock | PPurchaseAcquired | +75,000 | $16.14 | +$1,210,342.5 | 75,000 | Direct | |
| Aug 3, 2021 | Common Stock | CConversionAcquired | +1,323,530 | – | – | 1,398,530 | Direct | |
| Aug 3, 2021 | Common Stock | PPurchaseAcquired | +875,000 | $17.00 | +$14,875,000 | 2,273,530 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 | Common Stock | CConversionDisposed | −1,323,530 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.